Autonomix Medical CMO to receive CTF lifetime achievement award

Autonomix Medical, Inc. (NASDAQ: AMIX) announced that its co-founder and Chief Medical Officer, Robert Schwartz, M.D., has been named the recipient of the 2026 Cardiovascular Tech Forum Lifetime Achievement Award.

Dr. Schwartz is scheduled to be honored at Octane's 2026 Cardiovascular Tech Forum on September 18, 2026, in Newport Beach, California. The annual award recognizes individuals for contributions to cardiovascular technology through scientific achievement, clinical innovation and entrepreneurial leadership.

According to the company's press release, Dr. Schwartz has authored more than 500 scientific publications and holds more than 200 patents. He has also founded multiple medical technology companies, including co-inventing the Watchman device, which was later acquired by Boston Scientific.

"Rob's career has been defined by a relentless pursuit of innovation that has improved the lives of countless patients around the world," said Brad Hauser, President and Chief Executive Officer of Autonomix.

"I am honored to receive this recognition from the Cardiovascular Tech Forum," said Dr. Schwartz. "Innovation in medical technology has always been driven by collaboration among physicians, engineers and entrepreneurs committed to improving patient outcomes."

Autonomix Medical is a medical device company based in The Woodlands, Texas, focused on technologies for diagnosing and treating diseases involving the nervous system. The company's technology remains investigational and has not been cleared for marketing in the United States.

You May Also Be Interested In

• Autonomix Medical raises $4.9M via warrant inducement agreement
• Southern Cross Acquisition II prices $75M IPO on Nasdaq
• Lightspeed Commerce adds Rupal Hollenbeck to its board